Printer Friendly


Depression is one of midlife women's biggest concerns. That's why when I read Janet Currie's report on the Marketization of SSRIs, I knew I wanted to talk to her about her findings. The result is the Q&A cover feature this month. Janet is well-versed in this topic and I hope that you take away some valuable information to make the best decision for you and your mental health.

It's been two and a half years since I became the editor of A Friend Indeed. Over that time period, AFI has tackled many topics, from Endometriosis at Menopause (Nov/Dec 2003) to this month's feature on antidepressants. From the beginning of my tenure, I have tried to incorporate new ideas and explore novel areas of interest. Some of the new elements to the newsletter include columns on nutrition, fitness and alternative treatments. As a midlife woman myself, I have tried to get at the issues many of my friends, colleagues and conference-goers have asked me to explore. I hope I have provided enough information to answer many of your concerns.

So now, it is with regret that I announce that I will no longer be serving as editor. I have taken a fulltime position at another institution, which does not leave me time to devote my full attention to A Friend Indeed.

I wish you all a healthy menopause and midlife. Happy trails to you!

--June Rogers, Editor
COPYRIGHT 2006 A Friend Indeed Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Rogers, June
Publication:A Friend Indeed
Article Type:Editorial
Date:Jan 1, 2006
Previous Article:The overmarketing of antidepressants.
Next Article:The exchange.

Related Articles
The 8th Anniversary Editorial.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters